Personalized hypertension treatment recommendations by a data-driven model

Table 3 Summarized statistics of patients with effective deprescribing

	All patient visits	Visits with effective deprescribing
Mean age	60.93	65.05
Diabetes	44.69%	54.07%
Chronic systolic heart failure	2.32%	3.25%
Atherosclerotic heart disease	13.23%	18.86%
Peripheral vascular disease	7.29%	11.02%

Percentages in all patient visits are calculated as a fraction of the total number of patient visits in the test set (N = 31,758). The population in the effective deprescribing cohort consists of patients with better SBP control under deprescribing (M = 7241). All diseases refer to the corresponding diagnosis in ICD9/ICD10 (International Classification of Diseases) codes

ISSN: 1472-6947